Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2022 - 12/31/2022

Lobbyist name	Geoffrey Gallo
Business name	AstraZeneca Pharmaceuticals, LP
Address	3 Merles Lane
City, state, zip code	Stratham, NH 03885
Country	US
Agent type	Both
Phone	603-770-9000

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: AstraZeneca Pharmaceuticals Limited Partnership

Total amount paid by client; lobbyist is unable to report compensation at activity level: $22,000.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Senate Bill	2774	An Act investing in the future of our health.	Support	$0.00	N/A
House Bill	1131	An Act to protect taxpayer confidentiality	Support	$0.00	N/A
House Bill	1137	An Act relative to cancer patient access to biomarker testing to provide appropriate therapy	Support	$0.00	N/A
Senate Bill	771	An Act relative to pharmaceutical access, costs and transparency	Support	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Discussed continued impact to the Commonwealth of Massachusetts' health care system as it relates to Severe Acute Respiratory Syndrome Coronavirus 2 with the Health Policy Commission. Participated virtually on their quarterly meetings in the 2nd half of the year. Continued discussions with members of the Executive and Legislative branches concerning the development and potential rollout of AstraZeneca’s Severe Acute Respiratory Syndrome Coronavirus 2 vaccine and AstraZeneca’s monoclonal antibody Evusheld (for the prevention of Severe Acute Respiratory Syndrome Coronavirus 2).	Neutral	$0.00	N/A
House Bill	1278	An Act relative to prescription drug price transparency	Support	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	FY2023 Budget- section 111 extending the co-pay assistance law out to year 2026.	Support	$0.00	N/A
Executive	Executive Office of Health and Human Services (EOHHS)	Engaged in discussions related to indirect & direct price controls of prescription drugs. Engaged, as a member of the Health Policy Commission Advisory Council in the Health Policy Commission (HPC) Drug Pricing Review Process to include public comment and the Standard Reporting Form. Specifically the process for determining valuation of Rx drugs, transparency reporting requirements and rebate negotiations.	Oppose	$0.00	N/A
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

Date	Recipient name	Office sought	Amount
07/20/2022	Diana Dizoglio	State Auditor	$100.00
07/21/2022	Jon Santiago	State Representative, 9th Suffolk	$200.00
08/12/2022	Joe McGonagle	State Representative 28th Middlesex	$100.00
08/12/2022	Ken Gordon	State Representative 21st Middlesex	$100.00
09/28/2022	Marjorie Decker	State Representative 25th Middlesex	$200.00
10/06/2022	Jake Oliveira	State Senate Hampden, Hampshire & Worcester District district	$200.00
10/06/2022	Sue Moran	State Senate Plymouth and Barnstable district.	$200.00
10/10/2022	Jeff Roy	State Representative 10th Norfolk District	$200.00
11/02/2022	Sal DiDomenico	State Senate Middlesex and Suffolk district	$200.00
11/28/2022	Karen Spilka	State Senate 2nd Middlesex and Norfolk district	$200.00
		Total contributions	$1,700.00

Close this page

Connect with Us